skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Once-daily medications for the pharmacological management of ADHD in adults

Review

(2231) Views  (660) Full article downloads

Authors: Oleg v Tcheremissine, Lori M Lieving

Published Date May 2009 Volume 2009:5 Pages 367 - 369
DOI: http://dx.doi.org/10.2147/TCRM.S4206

Oleg v Tcheremissine1, Lori M Lieving2

1Department of Psychiatry, Behavioral Health Center – Carolinas Medical Center, Charlotte, NC, USA; 2Carolinas College of Health Sciences, Charlotte, NC, USA

Abstract: Attention-deficit/hyperactivity disorder (ADHD) is the most commonly diagnosed psychiatric disorder in children and adolescents. Symptoms of ADHD often persist beyond childhood and present significant challenges to adults. Pharmacotherapy is a first-line treatment option for ADHD across all age groups. The current review’s goals are (a) to critically examine the current state of knowledge regarding once-daily formulations of pharmacotherapies for treatment of adults with ADHD and (b) to provide clinicians with evidence-based information regarding the safety, efficacy and tolerability of once-daily medications for adult ADHD. The reviewed body of evidence strongly supports the use of pharmacotherapy as a first-line therapeutic option for the treatment of adults with ADHD. The once-daily pharmacological agents are effective therapeutic options for the treatment of adults with ADHD. In the US, based on the available evidence, once-daily medications are currently underutilized in adults with ADHD compared to pediatric population.

Keywords: adults, attention deficit/hyperactivity disorder, once-daily pharmacotherapies








Readers of this article also read:

Current trends in the treatment of polycystic ovary syndrome with desire for children
The benefits and risks of testosterone replacement therapy: a review
Finasteride in the treatment of patients with benign prostatic hyperplasia: a review
Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient  onsiderations and the role of lisdexamfetamine
Cancer prevention, aerobic capacity, and physical functioning in survivors related to physical activity: a recent review
Development and implementation of an online hybrid model for teaching evidence-based practice to health professions: processes and outcomes from an Australian experience
The economic impact of obesity in the United States
Effect of HIV infection on time to recovery from an acute manic episode
The effect of aging, nutrition, and exercise during HIV infection
Interprofessional education: a concept analysis